Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.770
+0.590 (14.11%)
Oct 23, 2025, 4:00 PM EDT - Market closed
Company Description
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.
The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025.
Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Turn Therapeutics Inc.
Country | United States |
Founded | 2015 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 4 |
CEO | Bradley Burnam |
Contact Details
Address: 250 N Westlake Blvd Westlake Village, California 91362 United States | |
Phone | 818 546 4011 |
Website | turntherapeutics.com |
Stock Details
Ticker Symbol | TTRX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0002023016 |
Employer ID | 32-0456090 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Bradley Burnam | Chief Executive Officer |
Zuraiz Chaudhary | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 22, 2025 | 8-K | Current Report |
Oct 9, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Oct 8, 2025 | 424B4 | Prospectus |
Oct 7, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Oct 7, 2025 | CERT | Certification by an exchange approving securities for listing |
Oct 7, 2025 | 8-A12B/A | Filing |
Oct 2, 2025 | 8-K | Current Report |
Sep 30, 2025 | EFFECT | Notice of Effectiveness |
Sep 29, 2025 | 8-A12B | Registration of securities |
Sep 24, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |